Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 11 to 20 of 21

TitleReference numberPublishedLast updated
Ofatumumab for treating relapsing multiple sclerosisTA699
Siponimod for treating secondary progressive multiple sclerosisTA656
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosisTA624
Ocrelizumab for treating primary progressive multiple sclerosisTA585
Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosisIPG640
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Multiple sclerosisQS108
Dimethyl fumarate for treating relapsing‑remitting multiple sclerosisTA320
Teriflunomide for treating relapsing–remitting multiple sclerosisTA303

Results per page

  1. 10
  2. 25
  3. 50
  4. All